Huapyong Kang

1.1k total citations
35 papers, 458 citations indexed

About

Huapyong Kang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huapyong Kang has authored 35 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huapyong Kang's work include Pancreatic and Hepatic Oncology Research (19 papers), Neuroendocrine Tumor Research Advances (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Huapyong Kang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), Neuroendocrine Tumor Research Advances (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Huapyong Kang collaborates with scholars based in South Korea, China and United States. Huapyong Kang's co-authors include Seungmin Bang, Moon Jae Chung, Si Young Song, Jeong Youp Park, Hee Seung Lee, Seung Woo Park, Jung Hyun Jo, Jae Hee Cho, Eui Joo Kim and In Rae Cho and has published in prestigious journals such as Annals of Oncology, Gastrointestinal Endoscopy and Surgical Endoscopy.

In The Last Decade

Huapyong Kang

34 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huapyong Kang South Korea 13 246 193 182 84 73 35 458
Ayşe Ocak Duran Türkiye 11 197 0.8× 96 0.5× 119 0.7× 65 0.8× 82 1.1× 44 439
Jianhua Wang China 12 176 0.7× 149 0.8× 86 0.5× 57 0.7× 181 2.5× 42 589
Madoka Kataoka Japan 12 148 0.6× 198 1.0× 148 0.8× 28 0.3× 40 0.5× 58 542
Inne Borel Rinkes Netherlands 12 163 0.7× 256 1.3× 156 0.9× 57 0.7× 22 0.3× 26 482
Nuriye Özdemir Türkiye 12 214 0.9× 85 0.4× 116 0.6× 68 0.8× 83 1.1× 43 450
И. С. Стилиди Russia 12 111 0.5× 114 0.6× 145 0.8× 96 1.1× 26 0.4× 103 372
Atsushi Takeshita Japan 13 279 1.1× 154 0.8× 140 0.8× 40 0.5× 174 2.4× 40 580
Lígia Traldi Macedo Brazil 12 298 1.2× 58 0.3× 174 1.0× 65 0.8× 42 0.6× 29 499
Oktay Bozkurt Türkiye 13 248 1.0× 59 0.3× 113 0.6× 105 1.3× 35 0.5× 44 427

Countries citing papers authored by Huapyong Kang

Since Specialization
Citations

This map shows the geographic impact of Huapyong Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huapyong Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huapyong Kang more than expected).

Fields of papers citing papers by Huapyong Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huapyong Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huapyong Kang. The network helps show where Huapyong Kang may publish in the future.

Co-authorship network of co-authors of Huapyong Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Huapyong Kang. A scholar is included among the top collaborators of Huapyong Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huapyong Kang. Huapyong Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Huapyong, So Jeong Kim, Eui Joo Kim, et al.. (2024). EUS-guided FNA and biopsy for cytohistologic diagnosis of gallbladder cancer: a multicenter retrospective study. Gastrointestinal Endoscopy. 100(2). 231–239.e2. 4 indexed citations
2.
Lee, Hee Seung, Jeehoon Kim, Huapyong Kang, et al.. (2024). Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicenter observational study. Therapeutic Advances in Medical Oncology. 16. 12724424–12724424.
3.
Kang, Huapyong, Bora Lee, Jung Hyun Jo, et al.. (2022). Machine-Learning Model for the Prediction of Hypoxaemia during Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care. Yonsei Medical Journal. 64(1). 25–25. 2 indexed citations
4.
Kang, Huapyong, Seung‐seob Kim, Jung Hyun Jo, et al.. (2022). Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer. Cancers. 14(19). 4672–4672. 11 indexed citations
5.
Cho, In Rae, Seok Hoo Jeong, Huapyong Kang, et al.. (2022). Diagnostic performance of endoscopic ultrasound elastography for differential diagnosis of solid pancreatic lesions: A propensity score-matched analysis. Pancreatology. 23(1). 105–111. 7 indexed citations
6.
Park, Se Woo, Kyong Joo Lee, Moon Jae Chung, et al.. (2022). Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial. Gastrointestinal Endoscopy. 97(1). 132–142.e2. 6 indexed citations
9.
Li, Kaifu, et al.. (2021). Development and validation of a novel 14-gene signature for predicting lymph node metastasis in papillary thyroid carcinoma. Gland Surgery. 10(9). 2644–2655. 6 indexed citations
10.
Lee, Hee Seung, Eun‐Young Kim, Jin‐Young Lee, et al.. (2021). Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer. EBioMedicine. 65. 103218–103218. 8 indexed citations
11.
12.
Kim, So Jeong, Huapyong Kang, Eui Joo Kim, Yeon Suk Kim, & Jae Hee Cho. (2020). Clinical features and outcomes of hypertriglyceridemia-induced acute pancreatitis: Propensity score matching analysis from a prospective acute pancreatitis registry. Pancreatology. 20(4). 617–621. 18 indexed citations
13.
Lee, Hee Seung, Huapyong Kang, Jung Hyun Jo, et al.. (2020). Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer. Cancer Chemotherapy and Pharmacology. 85(4). 651–659. 9 indexed citations
15.
Cho, In Rae, Huapyong Kang, Jung Hyun Jo, et al.. (2020). FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study. World Journal of Gastrointestinal Oncology. 12(2). 182–194. 42 indexed citations
16.
Jo, Jung Hyun, Huapyong Kang, Hee Seung Lee, et al.. (2018). KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study. Hepatobiliary & pancreatic diseases international. 18(1). 62–66. 2 indexed citations
17.
Kim, Eun Hye, Huapyong Kang, Chan Hyuk Park, et al.. (2015). The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis. Digestive and Liver Disease. 47(8). 663–668. 24 indexed citations
18.
19.
Lee, Hye Won, Moon Jae Chung, Huapyong Kang, et al.. (2014). Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature. Gut and Liver. 8(1). 109–112. 20 indexed citations
20.
Han, Tao, et al.. (2013). Cross‐sectional and dynamic change of serum metabolite profiling for Hepatitis B‐related acute‐on‐chronic liver failure by UPLC/MS. Journal of Viral Hepatitis. 21(1). 53–63. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026